Neoplasm by Cause — Trials

Neoplasm by Cause — Trials · CancerIndex

Clinical trials

Registered studies

708 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–100 of 236 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02911142	Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma	active not recruiting	Phase 1 / Phase 2	17	National Cancer Institute (NCI)NIH	1	Aug 26, 2026	clinicaltrials
NCT06016920	Safety and Efficacy of VB10.16 and Pembrolizumab in Patients With Head-Neck Squamous Cell Carcinoma	recruiting	Phase 1 / Phase 2	110	Nykode Therapeutics ASAINDUSTRY	7	Aug 26, 2026